BEDFORD, Texas, March 12, 2026 (GLOBE NEWSWIRE) — Legacy Housing Corporation (the “Company” or “Legacy”, NASDAQ: LEGH) today announced its financial results for the full year ended December 31, 2025. Financial HighlightsNet revenue for the year ended 2025 was $164.6 million, a decrease of 10.7% from the year ended 2024. Income from operations for the year ended 2025 was $48.4 million, a decrease of 23.9% from the year ended 2024. Net income for the year ended 2025 was $41.8 million, a decrease of 32.2% from the year ended 2024. Basic earnings per share for the year ended 2025 was $1.74, a decrease of 31.8% from the year ended 2024. Book value per share for the year ended 2025 was $22.20, an increase of 8.6% from the year ended 2024. Acquired certain assets of AmeriCasa Solutions LLC effective November 1, 2025, expanding our distribution...

HOUSTON, March 12, 2026 (GLOBE NEWSWIRE) — VAALCO Energy, Inc. (NYSE: EGY, LSE: EGY) (“Vaalco” or the “Company”) today reported operational and financial results for the fourth quarter and full year of 2025, including year-end 2025 reserves. Additionally, the Company provided operational and financial guidance for the first quarter and full year of 2026. 2025 Full Year Highlights:Sold 17,452 net revenue interest (“NRI”)(1) barrels of oil equivalent per day (“BOEPD”), above the high end of the Company’s increased guidance, while delivering production of 16,556 NRI(1) BOEPD or 21,160 working interest (“WI”)(2) BOEPD, both above the midpoint of Vaalco’s increased guidance; Reported full year (“FY”) 2025 net loss of $41.4 million ($0.40 per diluted share) and Adjusted Net Loss(3) of $4.0 million ($0.04 per diluted share); Generated...

FOURTH QUARTER EARNINGS OF $1.75 PER DILUTED COMMON SHARE CAPS 2025, ALONG WITH RECORD RECEIVABLES PURCHASES AND TRANSFORMATIONAL ACQUISITION ATLANTA, March 12, 2026 (GLOBE NEWSWIRE) — Atlanticus Holdings Corporation (NASDAQ: ATLC) (Atlanticus, the Company, we, our or us), a financial technology company that enables its bank, retail and healthcare partners to offer more inclusive financial services to millions of Everyday Americans, today announced its financial results for the fourth quarter ended December 31, 2025. An accompanying earnings presentation is available in the Investors section of the Company’s website at www.atlanticus.com or by clicking here. Financial and Operating Highlights Fourth Quarter 2025 Highlights (all comparisons to the Fourth Quarter 2024)Total operating revenue and other income increased 107.9% to...

NEWARK, Del., March 12, 2026 (GLOBE NEWSWIRE) — Artesian Resources Corporation (Nasdaq: ARTNA), a leading provider on the Delmarva Peninsula of water and wastewater services, and several other related business services, today announced earnings results for the fourth quarter and year ended December 31, 2025.Diluted net income per share increased 11.6% to $2.21 in 2025 Net income increased $2.4 million in 2025 Invested $58.8 million in 2025 in water and wastewater infrastructureYear-End Results Net income for the year ended December 31, 2025 was $22.8 million, a $2.4 million, or 11.9%, increase compared to net income recorded during the year ended December 31, 2024. Diluted net income per share increased 11.6% to $2.21, compared to $1.98 for the same period in 2024. Revenues totaled $112.9 million for the twelve months ended...

– Net Revenue for the Fourth Quarter of $118.8 Million and $319.9 Million for Full Year 2025 –– Gross Margin Improvement to 40.1% for the Fourth Quarter and to 37.3% for Full Year 2025 –– Net Income for the Fourth Quarter of $17.6 Million and $15.7 Million for Full Year 2025 –– Adjusted EBITDA for the Fourth Quarter of $28.1 Million and $40.1 Million for Full Year 2025 –– Initiating Full Year 2026 Revenue & Adjusted EBITDA Guidance – SAN DIEGO, March 12, 2026 (GLOBE NEWSWIRE) — Turtle Beach Corporation (Nasdaq: TBCH), a leading gaming accessories brand, today reported financial results for the fourth quarter and full year ended December 31, 2025 and provided full year 2026 guidance for net revenue and Adjusted EBITDA. Fourth Quarter HighlightsNet Revenue was $118.8 million. Gross Margins were 40.1%, a year-over-year improvement...

– Company to Host Webcast and Conference Call – BRANFORD, Conn., March 12, 2026 (GLOBE NEWSWIRE) — Sachem Capital Corp. (NYSE American: SACH) (the “Company”), a real estate lender specializing in originating, underwriting, funding, servicing, and managing a portfolio of loans secured by first mortgages on real property, today announced its financial results for the year ended December 31, 2025. John Villano, CPA, Sachem’s Chief Executive Officer, commented, “We closed 2025 with strong momentum and a continued focus on disciplined capital allocation and balance sheet strength. We’re taking decisive steps to address legacy exposures while positioning the company for meaningful value creation. As we move forward, we remain focused on originating high-quality, secured real estate loans under conservative underwriting standards,...

SUGAR LAND, Texas, March 12, 2026 (GLOBE NEWSWIRE) — TEAM, Inc. (NYSE: TISI) (“TEAM” or the “Company”), a global leading provider of specialty industrial services offering customers access to a full suite of conventional, specialized, and proprietary inspection, heat-treating, and mechanical services, today reported its financial results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter 2025 Highlights:Generated fourth quarter 2025 revenues of $224.8 million, an increase of 5.4% over the 2024 period. Grew gross margin to $58.3 million. Reported a net loss of $3.8 million, an improvement of $3.4 million from the 2024 period. Reduced Adjusted Selling, General and Administrative Expenses1 as a percentage of revenue to 20.0%, a reduction of 150 basis points from the 2024 period. Increased consolidated Adjusted...

HOUSTON, March 12, 2026 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals for central nervous system (CNS) cancers, today announces financial results for the fourth quarter and year ended December 31, 2025 and provides an overview of recent and upcoming business highlights. “Our team remains highly focused on achieving our 2026 targets,” said Marc H. Hedrick, M.D., Plus Therapeutics President and Chief Executive Officer. “Specifically, our top priority goals are CNSide commercial scale-up and REYOBIQ pivotal trial readiness; we also are looking aggressively for ways to over achieve where possible.” Q4 2025 AND RECENT HIGHLIGHTS CorporateCompleted an upsized public offering generating $15 million...

Net Revenue of $66.1 million for Q4 2025 and $260.6 Million for FY 2025  Gross Profit Margin of 52.1% for Q4 2025 and 52.3% for FY 2025 from continuing operations Q4 2025 Net Cash provided from continuing operations of $8.3 million and Free Cash Flow¹ of $6.6 million 14th consecutive quarter of positive Cash Flow from continuing operations and 10th consecutive quarter of positive Free Cash Flow¹ FY 2025 Net Cash provided from continuing operations of $33.9 million and Free Cash Flow¹ of $25.3 million TORONTO, March 12, 2026 (GLOBE NEWSWIRE) — TerrAscend Corp. (“TerrAscend” or the “Company”) (TSX: TSND) (OTCQX: TSNDF), a leading North American cannabis company, today reported its financial results for the fourth quarter and full year ended December 31, 2025. All amounts are expressed in U.S. dollars and...

Full-Year Net Revenue Increased 33% Y-O-Y to $18.8 Million and Fourth-Quarter Net Revenue up 22% Y-O-Y to $4.7 Million Reports Second Consecutive Year of Positive Net Income SOUTH ORANGE, N.J., March 12, 2026 (GLOBE NEWSWIRE) — Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced financial results for the fourth quarter and fiscal year ended December 31, 2025. Financial HighlightsFourth Quarter Ended December 31, 2025.Net revenue was $4.7 million, compared to $3.9 million in the fourth quarter of 2024, up 22% Net income was $62,000, compared to $349,000 during the same period in 2024 Adjusted EBITDA was $131,000, compared to $481,000 in the fourth quarter of 2024Year-End 2025Net revenue was $18.8 million, compared to $14.2 million...